The decrease in serum PON-1 is indicative of the idea that oxidative stress could be occurring in T. cruzi-seroreactive patients with an active infection that has not been controlled, and therefore suggesting that an anti-T. cruzi treatment should be provided. This evidence concerns the gene PON1 and infection.